"10.1371_journal.pone.0143919","plos one","2015-12-11T00:00:00Z","Victoria Arena de Souza; David J Scott; Joanne E Nettleship; Nahid Rahman; Michael H Charlton; Martin A Walsh; Raymond J Owens","UK OPPF-UK, The Research Complex at Harwell, Rutherford Appleton Laboratory Harwell Oxford, Oxfordshire, United Kingdom; Division of Structural Biology, Henry Wellcome Building for Genomic Medicine, University of Oxford, Roosevelt Drive, Oxford, United Kingdom; The Research Complex at Harwell, Rutherford Appleton Laboratory Harwell Oxford, Oxfordshire, United Kingdom; School of Biosciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington, Leicestershire, United Kingdom; Chroma Therapeutics Ltd., 93 Innovation Drive Milton Park, Abingdon, United Kingdom; Diamond Light Source, Harwell Science and Innovation Campus, Didcot, United Kingdom","Conceived and designed the experiments: RJO MAW MHC VAS DJS. Performed the experiments: VAS MAW DJS JEN NR. Analyzed the data: RJO VAS DJS MAW. Contributed reagents/materials/analysis tools: VAS MAW RJO DJS MHC JEN NR. Wrote the paper: VAS MAW RJO DJS MHC.","The study is a collaboration between University of Oxford and Diamond Light Source Ltd., which is a non-commercial and publicly funded UK national synchrotron research facility. I confirm that the part funding by Diamond Light Source Ltd. does not alter our adherence to all PLOS ONE policies on sharing data and materials. We have the following interests: this study received funding from Chroma Therapeutics Ltd. Michael H. Charlton was formerly employed by Chroma Therapeutics Ltd. and is currently employed by Inhibox. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","12","Victoria Arena de Souza","VADS",7,TRUE,5,5,4,5,TRUE,TRUE,FALSE,0,NA,FALSE
